nanoMAG® LLC, an engineered biomaterials manufacturer, is developing and commercializing next generation, high-strength, light-weight nanomagnesium biocompatible materials with applications in orthopaedic medicine.
Although our primary focus is the biomedical implant market opportunity, we have secondary market opportunities that benefit from the high strength-to-weight ratio of magnesium. These secondary markets include external fixation devices and braces as well as specialty products for recreational sports equipment and other manufacturing uses.
nanoMAG supplies precision magnesium sheet and short-run specialty alloys to diverse industries across the globe.
nanoMAG development projects have been sponsored by the following contracts:
- National Institutes of Health – Phase II SBIR on BioMg®
- National Science Foundation - Phase II STTR on TTMP Sheet
- Department of Defense/U.S. Army - Phase II SBIR on Armor
- BIRD Foundation - New Alloys for TTMP (with Dead Sea Magnesium)
nanoMAG® LLC is a subsidiary of Thixomat Technologies LLC - a company with more than 20 years experience in the research, development and marketing of technologies for the production of products utilizing magnesium alloys.
The nanoMAG team is comprised of the same industry experts that led the successful global business development of Thixomat and its revolutionary Thixomolding® process.
Thixomat is the developer of the Thixomolding® process that produces injection molded products from magnesium stock. The process permits the manufacture of net or near-net shape parts requiring little finishing. There are more than 50 Thixomat licensees and more than 500 Thixomolding® machines have been sold worldwide.